Neuroscience and rare disease therapeutics Loading... : Investor Sentiment and Bull/Bear Views
Loading chart...
Top Calls
No data yet
Price change since each call, adjusted for long/short direction. Results calculated:
Feed
21:50
Jan 12
Jan 12
Neuroscience, rare disease offer investable unmet need.
Neuroscience and rare disease are attractive because of huge unmet medical need: there are many large disease areas such as Alzheimer's and Lewy body dementia, and about 95% of rare diseases have no approved therapies, creating a strong opportunity for innovation.
HIGH
About Neuroscience and rare disease therapeutics Investor Commentary
Across the available history and selected sources, Buzzberg tracks Neuroscience and rare disease therapeutics across 1 sources: 1 bullish vs 0 bearish calls from 1 authors. Historical directional balance: 100% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 1 total trade idea tracked. Latest voices: Catherine Owen Adams.